Telix Pharmaceuticals TLPPF
NASDAQ TLPPF
$10.99 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Telix Pharmaceuticals (TLPPF) Property, Plant & Equipment (Net) (2023 - 2026)

Analysis

Telix Pharmaceuticals (TLPPF) Property, Plant & Equipment (Net) (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Amgen 212.49 Bn 198.50 Bn 7.24 Bn 8.55 Bn
2 Gilead Sciences 180.93 Bn 177.75 Bn 6.22 Bn 5.83 Bn
3 Vertex Pharmaceuticals 132.39 Bn 124.53 Bn 2.84 Bn 1.67 Bn
4 Regeneron Pharmaceuticals 82.17 Bn 74.18 Bn 3.93 Bn 5.46 Bn
5 Argenx Se 61.05 Bn 55.87 Bn 1.37 Bn 1.96 Bn
6 Moderna 55.19 Bn 50.05 Bn 52.00 Mn 2.06 Bn
7 Alnylam Pharmaceuticals 33.99 Bn 30.68 Bn 992.69 Mn 554.14 Mn
8 Biogen 31.30 Bn 30.01 Bn 1.96 Bn 2.99 Bn
9 Roivant Sciences 29.91 Bn 29.91 Bn 1.16 Mn 11.32 Mn
10 Telix Pharmaceuticals 3.72 Bn 3.43 Bn - 873.83 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 873.83 Mn
Dec 31, 2025 833.71 Mn
Dec 31, 2024 390.98 Mn
Dec 31, 2023 112.92 Mn